Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma
- 550 Downloads
Diffuse intrinsic pontine glioma (DIPG) is the deadliest central nervous system tumor in children. The survival of affected children has remained poor despite treatment with radiation therapy (RT) with or without chemotherapy. We reviewed the medical records of all surviving patients with DIPG treated at our institution between October 1, 1992 and May 31, 2011. Blinded central radiologic review of the magnetic resonance imaging at diagnosis of all surviving patients and 15 controls with DIPG was performed. All surviving patients underwent neurocognitive assessment during follow-up. Five (2.6 %) of 191 patients treated during the study period were surviving at a median of 9.3 years from their diagnosis (range 5.3–13.2 years). Two patients were younger than 3 years, one lacked signs of pontine cranial nerve involvement, and three had longer duration of symptoms at diagnosis. One patient had a radiologically atypical tumor and one had a tumor originating in the medulla. All five patients received RT. Chemotherapy was variable among these patients. Neurocognitive assessments were obtained after a median interval of 7.1 years. Three of four patients who underwent a detailed evaluation showed cognitive function in the borderline or mental retardation range. Two patients experienced disease progression at 8.8 and 13 years after diagnosis. A minority of children with DIPG experienced long-term survival with currently available therapies. These patients remained at high risk for tumor progression even after long follow-ups. Four of our long-term survivors had clinical and radiologic characteristics at diagnosis associated with improved outcome.
KeywordsDiffuse Glioma Long-term Neurocognitive Pontine Survivors
This work was supported by the US National Institutes of Health Cancer Center Support (CORE) Grant P30 CA21765 and by the American Lebanese Syrian Associated Charities (ALSAC). All procedures described in this manuscript were performed in compliance with clinical research regulations in the United States.
Conflict of interest
The authors declare that they have no conflict of interest.
- 11.Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE (1996) Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 77:555–562PubMedCrossRefGoogle Scholar
- 17.Wechsler D (2003) Wechsler intelligence scale for children. The Psychological Corporation, San AntonioGoogle Scholar
- 18.Wechsler D (2008) Wechsler adult intelligence scale. The Psychological Corporation, San AntonioGoogle Scholar
- 19.Woodcock RW, McGrew KS, Mather N (2001) Woodcock–Johnson tests of achievement III. Riverside Publishing, ItascaGoogle Scholar
- 20.Wechsler D (2002) Wechsler individual achievement test. The Psychological Corporation, San AntonioGoogle Scholar
- 21.Bryant BR, Wiederholt L, Bryant DP (2004) Gray diagnostic reading tests. PRO-ED Inc., AustinGoogle Scholar
- 22.Gioia GA, Isquith PK, Guy SC, Kenworthy L (2000) Behavior rating inventory of executive function. Psychological Assessment Resources Inc., OdessaGoogle Scholar
- 27.Kieran MW, Packer RJ, Onar A et al (2007) Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a pediatric brain tumor consortium study. J Clin Oncol 25:3137–3143PubMedCrossRefGoogle Scholar
- 30.Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment. Oxford University Press, New YorkGoogle Scholar